The Register · A provider

Imperial College London

London, United Kingdom · United Kingdom

Address & contact

https://www.imperial.ac.uk/news/articles/2026/ayahuasca-compound-has-significant-and-lasting-effect-on-depression-/

Specialties

psychedelic research clinical research mental health research psilocybin therapy treatment-resistant depression opioid addiction anorexia OCD fibromyalgia

Reports that name this provider

Ayahuasca Treatment Legality in United Kingdom: Home to Centre for Psychedelic Research (world's first dedicated centre for psychedelic research); partnership with Cybin UK for DMT depression trial; Phase IIa results showed single 21.5 mg intravenous DMT dose produced 7.4-point greater reduction in Montgomery–Åsberg Depression Rating Scale versus placebo; effects persisted up to six months in some participants
Psychedelic Treatment Quality in United Kingdom: Centre for Psychedelic Research established in 2019, world's first centre of its kind. Conducts trials at NIHR Clinical Research Facility at Hammersmith Hospital. Active trials span multiple indications.

← Back to all clinics